Biotech Values

[corpstrat]

<<DNA will free up nearly $50 billion in cash that will then find its way back into the smaller names.>>

Let's hope so. Nothing requires the money to stay in the biotech sector, but to the degree that the shareholders are biotech experts maybe they will favor stocks they understand well, over alternative investments.